Liver health follow-up study for type 2 diabetes
Part of Brain & nervous system, Heart & circulation, Hormones & metabolism, Lungs & breathing clinical trials.
This study follows up on people with type 2 diabetes who already took part in an earlier study about liver health. It uses an MRI scan to check the liver for fat and other changes, helping doctors understand the long-term impact of metabolic dysfunction-associated steatotic liver disease (MASLD).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You took part in the earlier EPSONIP study and completed all its assessments.
- You are 18 years old or older.
- You are able to provide informed consent.
- You do not have any metal implants or devices that make an MRI unsafe.
- You have not been diagnosed with another liver disease since the EPSONIP study began.
- You have not had a liver transplant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding a liver stiffness measurement to a lifestyle program helps people with MASLD (a type of fatty liver disease) improve their liver health. It is designed for people who have fatty liver and at least one sign of metabolic syndrome, like high blood pressure or diabetes.
This study screens people with overweight, obesity, or certain metabolic risk factors (like high blood pressure or diabetes) to find early signs of fatty liver disease and other liver problems. The goal is to improve prevention and early treatment through better screening.
This study looks at a new non-invasive screening method to predict metabolic dysfunction–associated steatotic liver disease (MASLD), a condition where fat builds up in the liver. The goal is to help identify people who may be at risk without needing invasive tests.
This study tests a new device called LiverScope® that scans your liver to detect fatty liver disease (MASLD). The scan uses special imaging technology and may help doctors diagnose liver disease more quickly and accurately.
This study is testing whether advanced imaging and other non-invasive methods can properly identify people with significant liver scarring due to metabolic liver disease or alcohol-related liver disease. It may help find better ways to track liver health without repeated needle biopsies.
This research studies fatty liver disease linked to metabolic problems like diabetes and obesity. You'll wear a fitness tracker and have liver imaging to help doctors understand the disease and find new treatments.
Hear when a new Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.